Quick Take: Thermo Fisher 2Q26 - Tools is back? (the print is positive, but we need to hear more from the call to know for sure)

Research evidence excerpt

Quick Take: Thermo Fisher 2Q26 - Tools is back? (the print is positive, but we need to hear more from the call to know for sure)

Eve Burstein +1 917 344 8313 eve.burstein@bernsteinsg.com 23 July 2026

• Except as noted above, the subject company has not been a client of SCB India during twelve months preceding the date

of distribution of this research report. Neither SCB India nor its Associates (i.e., affiliates/group companies) have received

compensation for products or services other than investment banking, merchant banking or brokerage services from the

subject company in the past twelve months.

• The principal research analyst(s) who prepared this report, members of the analysts' team, and members of their households

are not an officer, director, employee or advisory board member of the companies covered in the report.

• Our Compliance officer / Grievance officer is Ms. Rupal Talati, who can be reached at +91-22-68421451, or MUM-

BERNSTEIN-InCompliance@bernsteinsg.com / Scbin-investorgrievance@bernsteinsg.com

• The Research investor charter and Terms & Conditions of SCB India are available on its website and may be accessed at Sanford

C. Bernstein (India) Private Limited (https://bernsteinresearch.in/) for your reference.

• Disclaimer: Registration granted by SEBI, and certification from NISM, is in no way a guarantee of performance of the

intermediary or provide any assurance of returns to investors. Investments in securities market are subject to market risks. Read

all the related documents carefully before investing.

To our readers in Switzerland: This document is provided in Switzerland by or through Bernstein Autonomous LLP, and is

provided only to qualified investors as defined in article 10 of the Swiss Collective Investment Scheme Act (“CISA”) and related